DTCAs provoke consumers to request the advertised drug by giving them a false sense of needing the medication. In actuality, DTCA indirectly raises prices by “persuading” consumers to switch from a low-cost generic drug to a high-cost brand name drug, with little to no added benefits.5 DTCA can also increase prices directly due to the large costs associated with marketing. Since DTCA for drugs has increased from $200 million in 1997 to $4 billion in 2011, this money accounts for 37% of total drug promotion expenditures.5 These costs are made up for with an increased number of customers but also with raising the costs of the
DTCAs provoke consumers to request the advertised drug by giving them a false sense of needing the medication. In actuality, DTCA indirectly raises prices by “persuading” consumers to switch from a low-cost generic drug to a high-cost brand name drug, with little to no added benefits.5 DTCA can also increase prices directly due to the large costs associated with marketing. Since DTCA for drugs has increased from $200 million in 1997 to $4 billion in 2011, this money accounts for 37% of total drug promotion expenditures.5 These costs are made up for with an increased number of customers but also with raising the costs of the